标签：创新与研发

欧狄沃®获批成为中国首个胃癌免疫肿瘤治疗药物显著延长生存期，重振晚期胃癌治疗信心

2020年3月27日

· 欧狄沃是中国首个且目前唯一获批用于晚期胃癌治疗的免疫肿瘤药物； · 欧狄沃是目前唯一经Ⅲ期临床研究证实能为中国晚期胃癌患者带来生存获益的PD-1抑制剂； ...

安捷伦推出体外诊断质谱新品并获批用于临床

2020年1月17日

2020年1月16日，北京安捷伦科技公司（纽约证交所：A）今日宣布推出液相色谱串联质谱系统——一款经过验证的体外诊断医疗器械。同时，安捷伦还宣布该新品已获得中国国家药品监督管 ...

${"source":"editor","effects_tried":0,"photos_added":0,"origin":"gallery","total_effects_actions":0,"remix_data":["add_photo_directory"],"tools_used":{"tilt_shift":0,"resize":0,"adjust":0,"curves":0,"motion":0,"perspective":0,"clone":0,"crop":0,"flip_rotate":0,"selection":0,"enhance":0,"free_crop":0,"shape_crop":0,"stretch":0},"total_draw_actions":0,"total_editor_actions":{"border":0,"frame":0,"mask":0,"text":0,"lensflare":0,"clipart":0,"square_fit":0,"shape_mask":0,"callout":0},"source_sid":"3AE7318C-C1A3-4FD2-A981-42E03DF86EBB_1578991683918","total_editor_time":0,"total_draw_time":0,"effects_applied":0,"uid":"3AE7318C-C1A3-4FD2-A981-42E03DF86EBB_1578991683900","total_effects_time":0,"brushes_used":0,"height":1067,"layers_used":0,"width":1600,"subsource":"done_button"}$